18-mc

This Month in Psychedelics - August 2022

Policy

Following last month’s attempt to ban five novel psychoactive substances, which was later withdrawn, the DEA announced a plan to criminalize two additional psychedelic drugs—DOI and DOC. However, shortly after the announcement the DEA backed down and communicated that it no longer intends to place these two substances in Schedule I. While this may end up being a temporary victory, it is still a big win for now.

Industry

The psychedelic industry experienced a lot of movement this month. MindMed put an end to its 18-MC for opioid addiction program and slashed a lot of their early research and development projects. atai Life Sciences also decided to narrow its focus as well, cutting three programs: DemeRx’s noribogaine program, the non-psychedelic drug N-acetylcysteine for brain injury, and Salvinorin A for depression. And finally, Mydecine is looking like it is on the verge of closing due to a lack of funding.

Research

A randomized-clinical trial found that psilocybin-assisted psychotherapy is capable of treating alcohol use disorder. The study had a fairly small sample size of only 93 patients but the effect size was large, with the patients who received psilocybin reduced their drinking by 83% within eight months of their first dose.

Meanwhile, yet another placebo-controlled study found that psilocybin microdosing did not have any significant benefits to creativity, cognition, or perception. This study also had a small sample size, with only 34 participants, but it adds to the pile of evidence accumulating against the idea that microdosing has any tangible benefits that go beyond the placebo effect.

Miscellaneous

NFL football player Aaron Rodgers opened up about how he used ayahuasca to help him with his mental health and propel him to the point where he is at now in his career as the quarterback for the Green Bay Packers. This was a pretty big admission in the world of sports, where the use of illegal drugs is a big no-no. Fortunately both his coach and the league were accepting of the news, and hopefully this is the beginning of a trend because it would be great to see even more professional athletes come forward about their experiences with illegal drugs.

However, not all athletes got off so easy. WNBA star and two-time Olympic gold medalist Brittney Griner was sentenced to nine years in a Russian prison for the possession and smuggling of cannabis oil cartridges. Since then she has appealed the conviction and is hoping to overturn the ruling, but there’s no telling how this case will play out in court.

Wrapping up this month’s recap is a video of a wild bear who helped himself to a supply of psychedelic honey and ended up incapacitated in the back of a truck. Fortunately he turned out just fine after coming down from his trip, which I’m sure he’ll remember for the rest of his life!

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Weekly Psychedelic Links - August 2022

8.5.22

Cannabis

  • Brittney Griner sentenced to 9 years in Russian prison for drug possession and smuggling (Leafly)

  • Another American Caught With Weed in Russia Sentenced to 14 Years in Prison (High Times)

  • Cannabis no more of a risk than tobacco and alcohol – study (Cannabis Health News)

  • Federal Marijuana Records Would Be Expunged Under New Bipartisan Congressional Bill (Marijuana Moment)

  • New Study Says Legalization Hasn’t Caused More Teens To Try Cannabis (Marijuana Moment)

  • Cannabis Cafes Emerge in Post-Legalization Thailand (High Times)

  • Study Shows Cannabis Users 55% Less Likely to Develop Common Liver Cancer (High Times)

  • Arkansas Marijuana Campaign Files Lawsuit To Put Legalization Measure On Ballot After State Board’s Rejection (Marijuana Moment)

  • US weed homegrowers produce 8x more than Colorado legal market, says new report (Leafly)

  • Feds Seek Contractor To Help Test Marijuana Compounds In People’s Breath (Marijuana Moment)

  • New 3D Structures of Cannabinoid Receptor Inform Safer Drug Design (Psychedelic Science Review)

  • New Report Recommends Tips for Successful Cannabis-Impaired Driving Campaigns (High Times)

  • Colleges In States That Legalize Marijuana See A Boost In Application Numbers, Study Finds (Marijuana Moment)

  • Brazilian Government’s Selective Blindness to Cannabis Evidence (TalkingDrugs)

  • Largest Federal Workers Union Calls For Ending Marijuana Tests For Most Government Employees In Legal States (Marijuana Moment)

LSD

Magic Mushrooms

  • Psilocybin Microdosing Shows No Benefit to Creativity, Cognition, Perception in New Scientific Study (Willamette Week)

  • Oregon Psilocybin Rules Set To Be Finalized in December (High Times)

  • Lead Plaintiff in Canadian Right To Try Lawsuit Shares His Psilocybin Story (Lucid News)

  • The Rise of Casual Shrooms (VICE)

MDMA

  • It’s Festival Season! How Should We Group Dose MDMA? (Lucid News)

DMT

Ayahuasca

Mescaline

  • Mescaline: A Neglected Tool for Psychotherapy (Sam Woolfe)

Peyote

  • The Peyote Plot: The Indigenous Fight to Conserve the Sacred Plant and the Spiritual Medicine it Contains (DoubleBlind)

Synthetic Cannabinoids

Ketamine

  • Double-action mechanism found that makes ketamine less addictive (New Atlas)

  • How ketamine chic became the new heroin chic (Dazed)

Miscellaneous

  • Poll States 28% of Americans Have Tried At Least One Psychedelic Substance (High Times)

  • The Need for 100,000 Psychedelic Facilitators is Real (LA Weekly)

  • Morgan Stanley Publishes Optimistic Report on Psychedelics (Psychedelic Alpha)

  • California Bills To Legalize Psychedelics Possession, Allow Interstate Marijuana Commerce And More Teed Up For Key Hurdle Next Week (Marijuana Moment)

  • MindMed Board of Directors Approves Reverse Share Split (Psychedelic Alpha)

  • Majority Of Americans Support Psychedelics Research For Military Members, New Poll Finds As Bipartisan Reform Advances In Congress (Marijuana Moment)

8.12.22

Cannabis

  • Report: Spike in Marijuana Positives Fueling Truck Driver Shortage, Supply Chain Disruptions (NORML)

  • Ottawa on track to spend $200M per year on cannabis for veterans (CBC)

  • Wisconsin Governor Pardons Several for Cannabis Offenses (High Times)

  • Missouri will vote on marijuana legalization in November (Leafly)

  • Arkansas Supreme Court Orders State To Put Marijuana Legalization Initiative On Ballot, But Votes May Not Be Counted (Marijuana Moment)

  • Colorado Marijuana Shops Are 98 Percent Compliant With ID Checks To Prevent Underage Sales, State Regulators Say (Marijuana Moment)

  • Cannabis And Lower COVID Hospitalizations: Is There A Connection? Here’s What A New Study Found (The Fresh Toast)

  • Biden DOJ Says Medical Marijuana Patients Are Too ‘Dangerous To Trust’ In Motion To Dismiss Lawsuit On Gun Rights (Marijuana Moment)

  • Voters Across Wisconsin Will See Marijuana Questions On Their Ballots In November (Marijuana Moment)

  • ‘Very good for tourists’: Thailand aims for high season with U-turn on cannabis (The Guardian)

  • The (Possibly) Best and Worst Countries To Get Caught With Pot (Benzinga)

  • New Florida Marijuana Legalization Initiative Filed For 2024 Ballot, With Backing Of State’s Largest Medical Cannabis Company (Marijuana Moment)

  • Can memory loss be good? How cannabis can help with PTSD (Leafly)

  • Arresting illicit weed sellers repeats our drug war mistakes (NJ.com)

LSD

  • Neuroscience research suggests LSD might enhance learning and memory by promoting brain plasticity (PsyPost)

Magic Mushrooms

  • Psilocybin therapy is prompting states to reconsider laws about magic mushrooms (USA Today)

  • Many Oregonians will have to vote again on psilocybin (Oregon Capital Chronicle)

  • Buried Treasure: How Does Psilocybin Reduce Compulsivity? (Psychedelic Science Review)

  • Can Psilocybin Treat Obesity? New Evidence, Future Directions (Psychedelic Science Review)

  • Inside the lab that's creating enough psilocybin for everyone on Earth (Wisconsin Public Radio)

  • Phase 2 clinical trial to examine efficacy of psilocybin for anorexia nervosa (Healio)

  • Coos County cities move to ban psilocybin for medical use in their communities (KCBY)

  • Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient Advocate Thomas Hartle (Psychedelic Alpha)

MDMA

  • Las Vegas Wastewater Study Finds Absolutely Bonkers Spike In MDMA Levels During EDC (BroBible)

  • Where Ecstasy Meets Power: The Unique Risks of MDMA Therapy (Sam Woolfe)

Ayahuasca

  • Packers’ Aaron Rodgers Won’t Be Disciplined for Using Psychedelic Drug (Sports Illustrated)

  • Aaron Rodgers’ former Packers QB coach reacts to psychedelic drug revelation (New York Post)

Novel Psychoactive Substances

  • Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders (Psychedelic Alpha)

  • Majority of 'Bath Salt' Deaths Concentrated in Just Two States (Medpage Today)

  • Woman likely drowned after taking hallucinogenic drugs, coroner finds (Stuff.co.nz)

Synthetic Cannabinoids

  • States That Legalize Marijuana See ‘Significant Reductions’ In Synthetic Cannabinoid Poisonings, Study Finds (Marijuana Moment)

  • A 'very unpleasant time' - new synthetic drug in NZ (Radio New Zealand)

Nitrous Oxide

  • Urgent warning to parents over teens inhaling nitrous oxide after canisters found across Dublin (The Irish Sun)

Ketamine

  • How The Brain Changes In People With Chronic PTSD Following Ketamine Treatment (Healing Maps)

Miscellaneous

  • VR is as good as psychedelics at helping people reach transcendence (Technology Review)

  • The DARE Program Is Back in Some School Districts — Here’s What to Know (Teen Vogue)

  • Compass Pathways Sued for Stealing Trade Secrets (Psychedelic Spotlight)

  • An initiative to decriminalize most plant-based psychedelics is likely to fall short on signatures (Colorado Public Radio)

  • Colombia’s New President Wants to End the Drug War. Can He Succeed? (Filter)

  • Bear high on hallucinogenic 'mad honey' rescued in Turkey (Irish Mirror)

  • How Do We End the ‘War on Drugs’? Perhaps Scandinavia Has the Answer.. (Volteface)

  • Psychedelics are having a moment and women could be the ones to benefit (MIT Technology Review)

  • Over the counter culture: Are psychedelics coming to the corner shop? (The Independent)

  • Psychedelics researchers and investors should focus on delivering therapy, not drugs (STAT)

  • Muslims on Drugs: Psychedelics, Queerness, and Identity in the Post-9/11 Era (DoubleBlind)

  • What Role does Philosophy Play in the Future of Psychedelics? (TalkingDrugs)

  • First Reddit Community-Led Scientific Study to Launch on Quantified Citizen (Yahoo!)

  • Red Wall Voters Want Drug Law Reform – New Polling Shows (Volteface)

  • Psychedelic Clinical Trials and the Michael Pollan Effect (Psychedelic Spotlight)

  • Young Psychedelic Philanthropist Blazes Path for the Psychedelic Future (Lucid News)

  • Rediscovering Our Ancestral Roots of Exploration (Chacruna)

  • What Happens when Psychedelics Meets Video Games? (Lucid News)

8.19.22

Cannabis

  • Brittney Griner Appeals Conviction in Russian Drug Case (High Times)

  • North Dakota will vote on cannabis legalization in November (Leafly)

  • Arkansas court orders recreational cannabis amendment put back on ballot (Marijuana Business Daily)

  • Pot-smoking tourists not welcome in Thailand, says health minister (Reuters)

  • South Dakota Reservation Bans Alcohol, Allows Cannabis (High Times)

  • Analysis: Racial Disparities in Marijuana Possession Arrests Becoming More Pronounced in Prohibition States (NORML)

  • ‘Clean weed’ is about to be everywhere in California. Here’s what you need to know (Los Angeles Times)

  • Ohio Voters In Seven More Cities Will Decide On Marijuana Decriminalization At The Ballot This November (Marijuana Moment)

  • Idaho Activists Launch Medical Marijuana Ballot Push For 2024 (Marijuana Moment)

  • Alberta cannabis sales slow to grow as online identity verification deters consumers, say retailers (CBC)

  • Gallup: Those with First-Hand Experience with Cannabis Likely to Perceive It Positively (NORML)

  • Majority Of Texas Voters Support Marijuana Legalization, Poll Finds (Marijuana Moment)

  • Most Wisconsin Voters—Including Republicans—Support Legalizing Marijuana, Poll Shows (Marijuana Moment)

Magic Mushrooms

  • Is Oregon Ready for the Coming Psilocybin-Fueled Mushroom Tourism Boom? (Portland Monthly)

  • Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients (Psychedelic Alpha)

MDMA

  • Warnings over dangerously high-strength MDMA pills found at Boardmasters (Mixmag)

DMT

  • Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study (Psychedelic Alpha)

Ayahuasca

  • The Misfortune of “Right Wing” Psychedelia” in Brazil (Chacruna)

  • Anonymous Letter to Conservative Masters of the UDV (Chacruna)

Novel Psychoactive Substances

Nitrous Oxide

  • Atlanta neighbors frustrated by nitrous oxide use outside Widespread Panic show (KMIZ)

Ketamine

  • We Asked the Experts: What Exactly is in Ketamine? (TalkingDrugs)

Miscellaneous

  • Video of a forester who found a drunken bear gorged on hallucinogenic honey became a hit on the Internet (The Saxon)

  • California Psychedelics Legalization Bill Gutted by Key Committee (DoubleBlind)

  • Psychedelics as a sacrament? Lawsuit says drugs are a religious right. (The Washington Post)

  • Integration of psychedelic experiences linked to self-actualization via improvements in personal development and self-insight (PsyPost)

  • Two In Five Americans Say They’ve Changed Their Mind On Drug Policy, With Most Becoming “More Liberal,” Poll Finds (Marijuana Moment)

8.26.22

Cannabis

  • Federal Trade Commission issues refunds to CBD buyers, here’s why (Leafly)

  • Nebraska Officials Will Take A Second Look At Signatures For Rejected Medical Marijuana Ballot Measures (Marijuana Moment)

  • New medical marijuana campaign launches in Idaho for 2024 ballot (Marijuana Business Daily)

  • Study Shows 20% Increase in Frequency of Cannabis Consumption in Recreational States (High Times)

  • FBI Says CBD Use Is An ‘Automatic Disqualifier’ For Employment Despite Federal Hemp Legalization (Marijuana Moment)

  • Oklahoma’s legalization initiative at risk due to state delay (Leafly)

  • The casualties of California legalizing pot: Growers who went legal (The Washington Post)

  • U.S. Forest Service Reminds Workers Of Federal Marijuana Ban And Warns Against CBD Use (Marijuana Moment)

  • Dennis Rodman Proposes To Negotiate Russia Brittney Griner Release (High Times)

  • Why The Legal Cannabis Industry Needs The Black Market (Forbes)

  • Legalization Opponents Sue To Block Initiative From Missouri Ballot (High Times)

  • Cannabis for Chronic Pain Linked to Slightly Increased Risk of Arrhythmia (Healthline)

LSD

  • First Patient Dosed in Trial of LSD for Generalized Anxiety Disorder (Psychiatric Times)

Magic Mushrooms

  • Psilocybin May Help Treat Alcohol Addiction, Study Shows (TIME)

  • Three Out Of Four Oregon Counties Will Vote On Banning Or Postponing Psilocybin Services This November (Marijuana Moment)

  • Inside Paul Stamets’ Massive Microdosing Study (DoubleBlind)

Ayahuasca

  • Mormon Bishop And Former GOP Utah Rep. Champions Ayahuasca After Faith-Affirming Psychedelic Experience (Marijuana Moment)

5-MeO-DMT

  • Trip Advisors: Group Promotes 5-MeO-DMT Harm Reduction By Exposing Shamanic Hustlers (Forbes)

Novel Psychoactive Substances

  • The DEA is Attempting to Ban Two New Psychedelic Drugs (Psychedelic Spotlight)

  • Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment (Psychedelic Alpha)

  • BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects (Psychedelic Alpha)

Nitrous Oxide

  • Laughing Gas During Labor Is Becoming More Popular Among Women in the United States (People)

Ketamine

  • Ketamine’s upgrade to an employee benefit in US may hasten the legitimacy of psychedelics in SA (BizNews)

DXM

  • FDA Approves First, Only NMDA Receptor Antagonist for Major Depressive Disorder (Pharmacy Times)

Miscellaneous

  • Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses (Psychedelic Spotlight)

  • Psychedelics Use Increasing Among Adults, But Decreasing For Teens, New Federally Funded Studies Find (Marijuana Moment)

  • Psychedelic-occasioned mystical experiences linked to increased pro-environmental behaviors (PsyPost)

  • How near-death experiences and psychedelics alter attitudes about death (EurekAlert!)

  • Does Microdosing Actually Work? The Science Is Still Conflicted (VICE)

  • Issues of Patient Safety and Ethical Violations in Psychedelic Therapy (Psychedelic Science Review)

  • As Plant-Medicine Churches Grow, Legal Questions Linger (Lucid News)

  • This Psychedelic Theater Troupe Has Been Quietly Changing the World for Decades (DoubleBlind)

  • Do Psychedelic Trips Actually Start In The Gut Instead Of The Brain? (Healing Maps)

  • The Psychedelic Community Takes Itself Too Seriously (Psychedelic Alpha)

  • Ethics in Psychedelic Therapy: The Promises and Pitfalls of Increased Suggestibility (Sam Woolfe)

  • Do You Even Trip, Bro? On Psychedelic Masculinity (Psychedelic Spotlight)

  • How Long Can the Psychedelic Renaissance Last? (Psychedelic Spotlight)

  • The Legal Risks of Psychedelic Therapy and Coaching (EntheoNation)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.7.22

Cannabis

  • Sadiq Khan plans pilot to ‘decriminalise’ minor cannabis offences in London (The Guardian)

  • Legal recreational marijuana sales begin in Montana (KPAX)

  • Federal Marijuana Monopoly Finally Ends As Two Companies Harvest Cannabis Approved By DEA (Marijuana Moment)

  • New year rings in key changes to state marijuana markets (Marijuana Business Daily)

  • GOP-Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation (Marijuana Moment)

  • Colorado: Governor Issues Pardons to Over 1,300 Marijuana Offenders (NORML)

  • Wyoming Marijuana Activists Turn Focus To 2024 Ballot For Decriminalization And Medical Cannabis Initiatives (Marijuana Moment)

  • The top cannabis research studies of 2021 (Leafly)

  • Incoming Virginia GOP Governor Won’t ‘Overturn’ Legal Marijuana Possession, But Casts Doubt On Sales (Marijuana Moment)

  • Top Kansas Democrats Unveil Plan To Put Medical And Adult-Use Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

  • Two recreational marijuana initiatives might appear on Oklahoma ballot in fall (Marijuana Business Daily)

  • Iowa Democrats Unveil Marijuana Resolution To Put Legalization On Ballot For Voters To Decide (Marijuana Moment)

  • New Republican-Led Bill Would Legalize Medical Cannabis In Kentucky (Marijuana Moment)

  • South Dakota Lawmakers Prepare Dozens Of Cannabis Reform Bills (High Times)

  • Marijuana Decriminalization Reduces Arrests And Racial Disparities In Law Enforcement, Study Finds (Marijuana Moment)

  • Tiny but mighty: Micro-cultivators dominated 2021 (Leafly)

  • The cost of medical marijuana in Louisiana (KSLA)

  • Israeli startup a go-to resource in medical cannabis world (I24News)

  • Oklahoma Pot Farm Slapped with RICO From Next Door Neighbor (High Times)

  • Cannabis users report higher quality of life than non-users (Leafie)

Magic Mushrooms

  • Washington Psilocybin Bill Would Legalize Supported Adult Use (Bill of Health)

  • COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology (Psilocybin Alpha)

  • New Hampshire Bipartisan Bills Want to Reduce Penalties on Psilocybin, Other Drugs (Truffle Report)

  • Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder (Psilocybin Alpha)

  • Filament Health Announces Health Canada Approval for Phase II Trial Administering New Psilocybin Microdose Formulation (Psilocybin Alpha)

  • Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

  • Psilocybin therapy options could expand in Hawaiʻi (Hawai'i Public Radio)

MDMA

  • Drug testing: Dramatic drop in bath salts being sold as MDMA (Radio New Zealand)

  • Microdosing MDMA: What Research Says About Doing It For Mental Health Issues (Healing Maps)

DMT

  • Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee (Psilocybin Alpha)

Ayahuasca

  • IRS defends denial of Des Moines church's tax-free status over use of psychedelic drug (KCCI)

  • Anti-Drug GOP Senator Helps Psychedelic Church With Fight Against DEA And IRS (Marijuana Moment)

Iboga

  • National Institute on Drug Abuse to Test Ibogaine For Addiction Treatment (Truffle Report)

  • Caribbean Facility Finds Consistent Success Using Ibogaine for Anxiety and Trauma Treatment (PR Newswire)

Novel Psychoactive Substances

  • MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC (Psilocybin Alpha)

  • Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds (Psychedelic Spotlight)

Synthetic Cannabinoids

  • Using cannabinoids to treat obesity (Medical Xpress)

  • More needs to be done to tackle synthetic cannabinoids, experts say (Stuff.co.nz)

Ketamine

  • Awakn Life Sciences Expands World's First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions (Yahoo!)

  • PharmaTher Announces Publication of Research Data for KETABET™ (Psilocybin Alpha)

Miscellaneous

  • The Promises and Perils of Psychedelic Health Care (The New York Times)

  • Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy (Psychedelic Spotlight)

  • Magic mushroom companies are on the Nasdaq now. That’s a recipe for a bad trip (The Guardian)

  • Psychedelics Can Change Your View on the Nature of Reality (Psychedelic Spotlight)

  • Psychedelics in 2022: What to Expect (Truffle Report)

  • Fact Check-London Mayor not decriminalising drugs (Reuters)

  • Psychedelics 2021: A Year in Review (Psilocybin Alpha)

  • Will overdose deaths force an end to the US ‘war on drugs’? (Financial Times)

  • Philippines' Duterte says will never apologise for drug war deaths (Reuters)

  • New York Prisons Punished 1,600 People for False Drug Test Results (Filter)

  • Now psychedelics are coming to your medicine cabinet (ISRAEL21c)

  • How Psychedelic Therapy Fuses Indigenous Shamanism With Western Science (IFLScience)

  • Pop Culture Boosts Acceptance of Plant Medicine (GlobeNewswire)

  • Can A Psychedelic Experience Improve 2022? (Reality Sandwich)

  • Psychedelic Drug Policy Reform in 2021: A Year in Review (Psilocybin Alpha)

  • Psychedelics Will Have a Big Presence at SXSW in 2022 (Psychedelic Spotlight)

  • Was 2021 the Year Psychedelics Conquered Capitalism? (Green Entrepreneur)

  • Startup To Host Psychedelic Trips In The Metaverse (Forbes)

  • Is ‘The Trip’ Essential to The Psychedelic Experience? (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.23.21

ThisWeekinPsychedelics.png

Cannabis

  • Schumer Celebrates 4/20 Marijuana Holiday On Senate Floor (Marijuana Moment)

  • US House Passes Bill To Normalize Adult-Use Cannabis Commerce (NORML)

  • Virginia Governor Signs Marijuana Legalization Bill In Ceremonial Event—Even Though It’s Already Enacted (Marijuana Moment)

  • New Jersey Supreme Court Rules Company Must Cover Employee's Medical Marijuana Costs (MERRY JANE)

  • Nine In Ten Americans Support Legalizing Marijuana For Recreational Or Medical Use, New Pew Poll Finds (Marijuana Moment)

  • Florida Supreme Court Kills 2022 Marijuana Legalization Initiative That Hundreds Of Thousands Had Signed (Marijuana Moment)

  • Border weed: How the hometown of tater tots became a cannabis capital (Politico)

  • Louisiana Lawmakers Approve Bill To Legalize Medical Marijuana Flower For Patients (Marijuana Moment)

  • Veterans Medical Marijuana Safe Harbor Act Reintroduced (NORML)

  • Minnesota Marijuana Legalization Bill Clears Eighth Committee On Route To The House Floor (Marijuana Moment)

  • Two-thirds of La. voters support legalizing marijuana; state lawmakers on both sides of the aisle eye legalization (WAFB)

LSD

  • Today Is Bicycle Day, Which Isn’t Quite What You Think (Mother Jones)

  • LSD Side-Effects: Risks To Be Aware of When Consuming LSD (The Third Wave)

Magic Mushrooms

  • Oregon’s and Compass’s Opposite Approaches to Psilocybin Therapy Should Coexist, Says Initiator of Measure 109 (Chacruna)

  • Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application (Psilocybin Alpha)

MDMA

  • MDMA and magic mushrooms reconsidered for rescheduling by Therapeutic Goods Administration (The Canberra Times)

  • This is why sex on MDMA feels so good, according to experts (Gentside UK)

Ayahuasca

  • Advocacy Group Aims to Decriminalize Ayahuasca in Portland (Willamette Week)

  • Some Vermonters Turn to Ayahuasca as a 'Last Resort' to Heal Their Bodies and Minds (Seven Days)

5-MeO-DMT

  • Researchers In Europe, U.S. Team Up To Produce First Ever 5-MeO-DMT Psychedelic Training Program (Forbes)

  • Toad Conservation (Chacruna)

Peyote

  • Hello, Religious Privilege is Good and Here's Why (Patheos)

Novel Psychoactive Substances

Synthetic Cannabinoids

Ketamine

  • PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the Treatment of Parkinson’s Disease (Psilocybin Alpha)

  • Ketamine Infusion: How Ketamine Can Treat Depression, Anxiety, PTSD, and More (DoubleBlind)

PCP

  • State's medical expert to grand jury: 'Police didn't kill Daniel Prude' (WXXI News)

Miscellaneous

  • Norway opposition torpedoes plan to decriminalise drug use (France 24)

  • Washington State Lawmakers Downgrade Proposed Drug Possession Penalties Ahead Of House Floor Vote (Marijuana Moment)

  • Biden Is Allegedly Planning to Double Down on Trump's Prohibitionist Drug Policies (MERRY JANE)

  • MindMed To Commence Trading on Nasdaq (Psilocybin Alpha)

  • The “Equity Elephant”: Why Psychedelic Mutualism and Cooperatives are Crucial for an Accessible Future (Psychedelics Today)

  • Jewish psychedelics movement blasts off with first-ever conference (The Times of Israel)

  • ATAI Nasdaq IPO Plans Announced (Truffle Report)

  • Researchers Slam Drug War At Federally Hosted Psychedelics Event (Marijuana Moment)

  • There’s a Land Grab for Psychedelic Patents: Here’s What We Can Do About It (Psychedelic Times)

  • You're Not Hallucinating: Black People Are Being Left Out of the Psychedelic Renaissance (The Root)

  • People who regularly use psychoactive substances experienced negative impacts during COVID-19 (News-Medical.net)

  • Most Canadians not ready to expand drug legalization beyond cannabis: poll (Coast Reporter)

  • Extinction Rebellion founder says psychedelic drugs 'helped start environmental movement' (Wales Online)

  • Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica (Psilocybin Alpha)

  • Psychedelic Experience launches new website to help navigate the world of psychedelics (PR Newswire)

  • The Overlap Between Kink/BDSM and Psychedelics (Chacruna)

  • Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the Treatment of Depression and Addiction (Psilocybin Alpha)

  • Michael Pollan: A Catalyst to the Psychedelic Renaissance (The Third Wave)

  • If You're Going to Solo Trip On Psychedelics, Bear This in Mind (VICE)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.12.21

ThisWeekinPsychedelics.png

Cannabis

  • Mexican lawmakers advance bill to legalize recreational cannabis (Leafly)

  • Hawaii Senate Approves Marijuana Legalization Bill And Separate Decriminalization Expansion Proposal (Marijuana Moment)

  • Virginia Governor Considers Speeding Up Legal Marijuana Timeline (Marijuana Moment)

  • South Dakota: Legislative Effort to Delay Implementation of Voter-Approved Medical Marijuana Law Fails (NORML)

  • Mississippi House kills medical marijuana bill. Senate tries a hail Mary (Mississippi Today)

  • Legislation Introduced To No Longer Deny Citizenship Based on Cannabis Consumption (NORML)

  • Thai households now allowed to grow six cannabis plants a year (BusinessLIVE)

  • New cannabis coalition wants to influence how — not if — weed is legalized (Politico)

  • Rhode Island Senate Leaders Unveil Marijuana Legalization Bill As Governor Prepares Competing Plan (Marijuana Moment)

  • Lawmakers In Several States Consider Enacting or Expanding Medical Cannabis Access (NORML)

  • Nearly 30,000 Californians Just Had Felony Weed Offenses Reduced to Misdemeanors (MERRY JANE)

  • Review: Cannabinoids Effective and Well-Tolerated in Patients with Post-Traumatic Stress (NORML)

  • Plymouth Massachusetts Introduces a New Medical Research Website for Cannabis (PR Newswire)

  • Indoor Weed Farms Are Hotboxing the Planet (Gizmodo)

  • Vaping Weed May Actually Be Worse for Your Lungs Than Smoking Cigarettes, Study Says (MERRY JANE)

LSD

  • Psychedelics research: Scientists zero in on the ideal dose of LSD to use in psychiatric treatment (PsyPost)

  • LSD Brings Your Brain to the Edge of Chaos (VICE)

  • When Acid Makes You Feel Like Jesus (DoubleBlind)

Magic Mushrooms

  • New York Lawmaker Files Bill To Decriminalize Psilocybin Mushrooms (Marijuana Moment)

  • DEA Sued By Doctor Who Wants Permission To Give Psilocybin Mushrooms To Patients (Marijuana Moment)

  • Mind Medicine Australia urges TGA to reverse its Interim Decision on scientific and humanitarian grounds (Mind Medicine Australia)

  • Psilocybin Therapy Could Help With Obesity (Baystreet)

  • How Red Light Holland Is Bringing Psilocybin Truffles Mainstream (Benzinga)

MDMA

  • The impact COVID-19 had on MDMA this festival season (Newshub)

DMT

Ayahuasca

  • Best Ayahuasca Retreats: How to Choose the Right Ayahuasca Retreat For You (DoubleBlind)

5-MeO-DMT

  • Three Friends Explore The Obscure And Potent Substance 5-MeO-DMT In This Existentially Intense Film Doc (Forbes)

Iboga

Novel Psychoactive Substances

Ketamine

  • Yes, Ketamine Addiction Is a Thing. Here’s What You Need to Know. (DoubleBlind)

  • Intravenous ketamine appears safe, efficacious for adolescents with depression (Healio)

  • Lower dose of ketamine is as effective as the standard dose to treat pain in adults (News-Medical.net)

  • Best Ketamine Clinics and Therapists: What to Look for if You’re Seeking Ketamine Therapy, and How to Find Ketamine Clinics Near You (DoubleBlind)

Miscellaneous

  • Investors Are Debating Who Should Own the Future of Psychedelics (VICE)

  • The Race to Patent Psychedelics Is Just Getting Started (VICE)

  • Vermont Lawmakers Propose Decriminalizing Drugs (Truffle Report)

  • Michigan Activists Launch Statewide Campaign to Decriminalize Entheogenic Plants, Fungi (Truffle Report)

  • Why mental health researchers are studying psychedelics all wrong (Salon)

  • Report finds people use psychedelic drugs to self-medicate for depression, anxiety and trauma (TheJournal.ie)

  • Some Thoughts on For-Profit Psychedelic Startups and Companies (Tim Ferriss)

  • An open letter to Tim Ferriss about the value of patents in the psychedelic world (LinkedIn)

  • How to Penetrate Clubhouse’s Psychedelic Underground (Lucid News)

  • California May Ban Most Employers From Drug Testing People Upon Employment (MERRY JANE)

  • Lifetime psychedelic use may reduce likelihood of hypertension (Healio)

  • Psychedelic Speech: How Drugs Disorganize Normal Communication Patterns (Psychedelic Science Review)

  • New Coalition Seeks Federal Psychedelic Research Funds (Truffle Report)

  • The Outlaw Chemists Who Deserve a Cut of the Psychedelic Gold Rush (The New Republic)

  • Gurus Behaving Badly: Anaïs Nin’s Diary & the Value of Gossip (Chacruna)

  • The Pitfalls and Challenges of Psychedelic Medicine (Psychedelic Science Review)

  • Psychedelics and Ancient Art: A History of Confirmation Bias (Truffle Report)

  • The Shamanic Persona (Maps of the Mind)

  • Psychedelic Science Holds Promise for Mainstream Medicine (UNLV)

  • Seeking a True Shaman in the Sierra Mazateca (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.